Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 200,786
  • Shares Outstanding, K 27,355
  • Annual Sales, $ 3,500 K
  • Annual Income, $ -54,190 K
  • 60-Month Beta 1.49
  • Price/Sales 57.52
  • Price/Cash Flow N/A
  • Price/Book 12.36
Trade ABEO with:

Options Overview Details

View History
  • Implied Volatility 172.55% ( +129.25%)
  • Historical Volatility 94.19%
  • IV Percentile 93%
  • IV Rank 62.38%
  • IV High 250.79% on 08/15/23
  • IV Low 42.79% on 06/09/23
  • Put/Call Vol Ratio 6.05
  • Today's Volume 141
  • Volume Avg (30-Day) 195
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 3,888
  • Open Int (30-Day) 3,891

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.50
  • Number of Estimates 1
  • High Estimate -0.50
  • Low Estimate -0.50
  • Prior Year -0.54
  • Growth Rate Est. (year over year) +7.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.65 +11.58%
on 03/18/24
9.01 -17.65%
on 03/06/24
+0.52 (+7.54%)
since 02/28/24
3-Month
4.02 +84.37%
on 01/31/24
9.01 -17.65%
on 03/06/24
+2.28 (+44.36%)
since 12/28/23
52-Week
2.65 +180.00%
on 03/29/23
9.01 -17.65%
on 03/06/24
+4.64 (+166.91%)
since 03/28/23

Most Recent Stories

More News
Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 7.28 (-0.82%)
Abeona Therapeutics: Q2 Earnings Snapshot

Abeona Therapeutics: Q2 Earnings Snapshot

ABEO : 7.28 (-0.82%)
Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 7.28 (-0.82%)
Three Small-Cap Biotech Stocks to Consider Now

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 

HARP : 23.01 (+0.09%)
HTGM : 0.4800 (-20.00%)
ABEO : 7.28 (-0.82%)
Philips (PHG) Showcases New AI-Based Solutions at the RSNA

Koninklijke Philips (PHG) banks on its new AI solutions to address issues faced by Radiology experts in the healthcare industry and drive prospects.

PHG : 20.11 (-1.08%)
AGEN : 0.5624 (+1.08%)
ABEO : 7.28 (-0.82%)
ACRS : 1.2450 (-1.19%)
Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 7.28 (-0.82%)
Philips (PHG) to Showcase New Innovations & Cardiac Solutions

Philips (PHG) is launching cardiac solutions to further benefit from its tried-and-tested strategic operational decision to build new products to attract more customers.

PHG : 20.11 (-1.08%)
AGEN : 0.5624 (+1.08%)
ABEO : 7.28 (-0.82%)
ACER : 0.6601 (-17.95%)
Philips (PHG) Expands Partnership to Build Angio CT Solution

Philips (PHG) is building the world's first spectral detector angio CT solution by forging an alliance with the Leiden University Medical Center.

GE : 176.16 (-2.20%)
PHG : 20.11 (-1.08%)
ABEO : 7.28 (-0.82%)
ACER : 0.6601 (-17.95%)
Philips (PHG) Alerts Users of Health Hazards of Therapy Masks

Philips (PHG) cautions customers against health hazards faced by the users of CPAP or Bi-Level PAP therapy masks with magnetic headgear.

GE : 176.16 (-2.20%)
PHG : 20.11 (-1.08%)
ABEO : 7.28 (-0.82%)
ACER : 0.6601 (-17.95%)
Abeona Therapeutics Reports Second Quarter 2022 Financial Results

Disposition of MPS programs allows Abeona to extend runway of current cash into 2Q 2023 Phase 3 VIITALâ„¢ study topline data expected in late-3Q/early-4Q...

ABEO : 7.28 (-0.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 7.88
2nd Resistance Point 7.74
1st Resistance Point 7.54
Last Price 7.28
1st Support Level 7.21
2nd Support Level 7.07
3rd Support Level 6.87

See More

52-Week High 9.01
Last Price 7.28
Fibonacci 61.8% 6.58
Fibonacci 50% 5.83
Fibonacci 38.2% 5.08
52-Week Low 2.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar